INTERNATIONAL PATENT: ZEVRA THERAPEUTICS, INC. FILES APPLICATION FOR "USE OF ARIMOCLOMOL IN ACTIVATING CLEAR GENE EXPRESSION AS TREATMENT FOR LYSOSOMAL STORAGE DISORDERS"

GENEVA, Jan. 13 -- ZEVRA THERAPEUTICS, INC. (1180 Celebration Blvd., Suite 103Celebration, Florida 34747) filed a patent application (PCT/US2025/035973) for "USE OF ARIMOCLOMOL IN ACTIVATING CLEAR GENE EXPRESSION AS TREATMENT FOR LYSOSOMAL STORAGE DISORDERS" on Jun 30, 2025. With publication no. WO/2026/010888, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUENTHER, Sven (913 Forest Edge CircleCoralville, 52241), MICKLE, Travis (c/o Zevra Therapeutics, Inc.1180 Celebration Blvd.Celebration, Florida 34747), JENSEN, Thoma...